CVS HEALTH REPORTS STRONG SECOND QUARTER RESULTS, RAISES 2022 FULL-YEAR EPS AND CASH FLOW FROM OPERATIONS GUIDANCE
Go back to CVS HEALTH REPORTS STRONG SECOND QUARTER RESULTS, RAISES 2022 FULL-YEAR EPS AND CASH FLOW FROM OPERATIONS GUIDANCE| CVS Caremark Corp. (NYSE: CVS) | Delayed: 102.57 +4.25 (4.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $98.32 | 52 Week High | $106.67 | |||
| Open | $99.79 | 52 Week Low | $69.30 | |||
| Day High | $102.64 | P/E | 27.35 | |||
| Day Low | $99.00 | EPS | $3.75 | |||
| Volume | 1,606,208 | |||||

